Loading clinical trials...
Loading clinical trials...
People who undergo allogeneic bone marrow transplant for blood cancers receive the highest chemotherapy doses possible that humans can receive and still survive. As a result, they have devastating sid...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alberta
NCT05855707 · Allogeneic Disease, GVHD,Acute, and more
NCT03343834 · Epstein-Barr Viraemia, Hematologic Diseases, and more
NCT03149952 · Allogeneic Disease, Hematopoietic Stem Cell
University of Alberta
Edmonton, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions